Get started
Author

Edoardo Cellupica

Observed name: E. Cellupica
Institution: Italfarmaco (Italy)
ORCID: 0000-0002-6362-9848
Observed ORCID: 0000-0002-6362-9848
OpenAlex ID: A5072301640
Vinca alkaloids and analogues as anti-cancer agents: Looking back, peering ahead
2018 · Emanuela Martino, Giuseppe Casamassima, et al. · Bioorganic & Medicinal Chemistry Letters · 359
Novel Benzohydroxamate-Based Potent and Selective Histone Deacetylase 6 (HDAC6) Inhibitors Bearing a Pentaheterocyclic Scaffold: Design, Synthesis, and Biological Evaluation
2019 · Barbara Vergani, Giovanni Sandrone, et al. · Journal of Medicinal Chemistry · 57
Difluoromethyl-1,3,4-oxadiazoles are slow-binding substrate analog inhibitors of histone deacetylase 6 with unprecedented isotype selectivity
2022 · Edoardo Cellupica, Gianluca Caprini, et al. · Journal of Biological Chemistry · 48
PDF
Mechanistic and Structural Insights on Difluoromethyl-1,3,4-oxadiazole Inhibitors of HDAC6
2024 · Edoardo Cellupica, Aureliano Gaiassi, et al. · International Journal of Molecular Sciences · 15
PDF
The Importance of the “Time Factor” for the Evaluation of Inhibition Mechanisms: The Case of Selected HDAC6 Inhibitors
2023 · Edoardo Cellupica, Gianluca Caprini, et al. · Biology · 7
Abstract 7058: Highly selective HDAC6 inhibitors: Are they the answer for immunomodulation.
2026 · Silvia Rizzo, Edoardo Cellupica, et al. · Cancer Research
Methods for the kinetic analysis of time-dependent HDAC6 inhibitors
2026 · Edoardo Cellupica, Gianluca Fossati, et al. · Methods in enzymology on CD-ROM/Methods in enzymology
HDAC6 inhibitor ITF3791 enhances alloantigen presentation capabilities of myeloid cells modulating PD-L1 expression and co-stimulatory molecules
2019 · C. Ripamonti, C. Steinkuhler, et al. · European Journal of Cancer
Works count: 9
Citation count: 486
H-index: 5
I10-index: 4
Year
Topic
Type